Condition: Human Papilloma Virus Related Cervical Carcinoma · Sponsor: Tulane University
This proposal directly addresses the ability to safely scale-up a Screen-Triage-Treat approach to cervical cancer screening. The investigators propose to capitalize on a pool of screen-eligible women accessing routine care within targeted human immunodeficiency virus (HIV) care and treatment services. The primary outcome of interest is the number of women screened and the proportion of screen-positive women undergoing treatment. Secondary outcomes will focus on other implementation outcomes, and if successful, will be utilized to inform future research to take this approach to scale across Mozambique.
This description comes directly from the study's public registry record.
Kathryn Kampa, MPH · 651-983-1076 · kkampa@tulane.edu
Harriett Myers, MPH · 828-292-1742 · hmyers5@tulane.edu
Always discuss trial participation with your own doctor first.
| University Eduardo Mondlane (UEM) | Maputo, Mozambique | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06810739